Abstract |
We studied the effects of the new antioxidant drug U-83836E during splanchnic artery occlusion (SAO) shock in the rat. Serum tumor necrosis factor ( TNF-alpha), white blood cell (WBC) count, mean arterial blood pressure (MAP), survival rate and the responsiveness to acetylcholine of aortic rings were investigated. SAO shock produced a marked increase in serum TNF-alpha (241.4 +/- 18.2 U/ml vs Not Detectable in basal), reduced MAP (51.4 +/- 4 mmHg vs 85.1 +/- 5 mmHg), survival time (80 +/- 10 min vs > 240 min), WBC count (2.8 +/- 0.4 x 10(3)/mm3 cells vs 11.7 +/- 0.9 x 10(3)/mm3 cells) and blunted the responsiveness to ACh of aortic rings (60 +/- 3% tension vs 23 +/- 4% tension). The analogue of vitamin E, U-84836E, administered at onset of reperfusion, lowered serum TNF-alpha (38.4 +/- 6.5 U/ml; p < 0.001), improved MAP (67.5 +/- 3.8 mmHg; p < 0.001), WBC count (8.9 +/- 0.6 x 10(3)/mm3; p < 0.001), and survival time (235 +/- 15 min; p < 0.001), and restored the responsiveness to ACh of aortic rings (32 +/- 3.7% tension; p < 0.001). These preliminary data suggest that this new compound could be a promising drug in shock therapy.
|
Authors | G M Campo, F Squadrito, S Campo, D Altavilla, B Longoni, A Saitta, G Squadrito, A P Caputi |
Journal | Free radical research
(Free Radic Res)
Vol. 28
Issue 5
Pg. 477-84
(May 1998)
ISSN: 1071-5762 [Print] England |
PMID | 9702528
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antioxidants
- Chromans
- Piperazines
- Protective Agents
- Tumor Necrosis Factor-alpha
- Vasodilator Agents
- U 78517F
- Acetylcholine
|
Topics |
- Acetylcholine
(pharmacology)
- Animals
- Antioxidants
(pharmacology)
- Arterial Occlusive Diseases
(complications, drug therapy)
- Blood Pressure
(drug effects)
- Chromans
(pharmacology)
- Ischemia
(prevention & control)
- Leukocyte Count
(drug effects)
- Lipid Peroxidation
(drug effects)
- Male
- Piperazines
(pharmacology)
- Protective Agents
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Shock
(etiology, prevention & control)
- Splanchnic Circulation
(drug effects)
- Survival Rate
- Tumor Necrosis Factor-alpha
(metabolism)
- Vasodilator Agents
(pharmacology)
|